ED
CAA

Exane Derivatives’s CalAtlantic Group, Inc. CAA Stock Holding History

Exane Derivatives’s Portfolio CAA Stock Details CAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$35 – 668
2017
Q2 		$35 Hold
1
– – ﹤0.01% 600
2017
Q1 		$37 Hold
1
– – ﹤0.01% 527
2016
Q4 		$34 Hold
1
– – ﹤0.01% 593
2016
Q3 		$33 Hold
1
– – ﹤0.01% 579
2016
Q2 		$37 Sell
1
-2
-67% -$70 ﹤0.01% 508
2016
Q1 		$100 Sell
3
-42
-93% -$1.31K ﹤0.01% 532
2015
Q4 		$1.71K Buy
45
+23
+105% +$919 ﹤0.01% 381
2015
Q3 		$864 Hold
22
– – ﹤0.01% 437
2015
Q2 		$971 Sell
22
-1
-4% -$43 ﹤0.01% 441
2015
Q1 		$1.03K Sell
23
-17
-43% -$677 ﹤0.01% 445
2014
Q4 		$1.46K Buy
+40
New +$1.48K ﹤0.01% 467

Other funds holding CAA

MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Exane Derivatives's CAA Position: Q3 2017 in Review

Exane Derivatives sold out of CalAtlantic Group, Inc. (CAA) in Q3 2017, closing a stake of 1 share — an estimated $35 sold.

Exane Derivatives first reported a position in CAA in Q4 2014 and held it in 11 quarters. The position peaked at $1.71K in Q4 2015. 249 funds tracked by Wall St. Rank hold CAA as of Q3 2017.

  • Exane Derivatives reported no remaining CalAtlantic Group, Inc. position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 CalAtlantic Group, Inc. share in Q3 2017, an estimated $35.
  • Exane Derivatives first reported a position in CalAtlantic Group, Inc. in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's CalAtlantic Group, Inc. position peaked at $1.71K in Q4 2015.
  • 249 funds tracked by Wall St. Rank held CalAtlantic Group, Inc. as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.